MARKET

INO

INO

Inovio Pharmaceu
NASDAQ
1.740
+0.060
+3.57%
After Hours: 1.780 +0.04 +2.30% 19:49 03/06 EST
OPEN
1.690
PREV CLOSE
1.680
HIGH
1.770
LOW
1.680
VOLUME
583.06K
TURNOVER
--
52 WEEK HIGH
2.979
52 WEEK LOW
1.300
MARKET CAP
119.54M
P/E (TTM)
-0.6606
1D
5D
1M
3M
1Y
5Y
1D
Earnings week ahead: ORCL, ADBE, LI, NIO, HPE, ZIM, KSS, and more
Seeking Alpha · 11h ago
Inovio Pharmaceuticals Inc. published an update to their financial calendar
Reuters · 3d ago
Rosen Law Firm Urges Inovio Investors to Act Before April 7 Lead Plaintiff Deadline
Reuters · 3d ago
Inovio Faces Securities Class Action Lawsuit Over FDA Review Timeline Disclosure
Reuters · 4d ago
Akeso, INOVIO Collaborate To For Evaluation Of Akeso's Cadonilimab PD-1/CTLA-4 Bispecific AntibodyIn Combination With INO-5412 To Treat Glioblastoma
Benzinga · 4d ago
Akeso, INOVIO team up to test cadonilimab plus INO-5412 in GBM trial
Reuters · 4d ago
Inovio, Akeso announce clinical collaboration
TipRanks · 4d ago
INOVIO - DOSING IN COMBINATION THERAPY TRIAL EXPECTED TO BEGIN IN H2 2026
Reuters · 4d ago
More
About INO
Inovio Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing deoxyribonucleic acid (DNA) medicines to help treat and protect people from human papillomavirus (HPV)-related diseases, cancer, and infectious diseases. Its proprietary investigational CELLECTRA devices are designed to deliver the plasmids into the body’s cells for optimal effect, without the use of chemical adjuvants, lipid nanoparticles or viral vectors. Its lead candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease caused by HPV-6 and HPV-11. Its DNA medicines in the pipeline include INO-3112 for the Treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma, VGX-3100 for the Treatment of HPV-related Cervical HSIL, VGX-3100 for the Treatment of Anal or Perianal HSIL, INO-5401 for the Treatment of Glioblastoma Multiforme (GBM), and INO-5401 for the Prevention of Cancer for People with BRCA1/2 Mutation.

Webull offers Inovio Pharmaceuticals Inc stock information, including NASDAQ: INO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INO stock methods without spending real money on the virtual paper trading platform.